Tango Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$21.75

-1.74 (-7.41%)

As of Sep 20, 10:10 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 17 89%

Hold 2 11%

Sell 0 0%

Price Target

Analyst Price Target +29.8% upside

Low Target $22.54

Average Target $28.24

High Target $42.65

Current Price $21.75

Current
$21.75

Target
$28.24

$22.54 $28.24 avg $42.65

Scenario Analysis

Bear Case

$22.54

3.6%

Low target

Base Case

$28.24

+29.8%

Avg target

Bull Case

$42.65

+96.1%

High target

Risk/Reward

26.5x

Highly favorable

Price in Context

52-Week High

$34.39

-36.8% from high

52-Week Low

$6.69

+225.1% from low

Target vs 52W High

$28.24

-17.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.9%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%